Because blends contain more than one active compound, there are some important research considerations: Composition transparency : Always check the specific product listing and accompanying Certificate of Analysis (COA) for the exact compounds and ratios included in a given blend batch, as formulations can differ between suppliers and batches Analytical complexity : HPLC and mass spectrometry analysis of a multi-component blend is inherently more complex than for a single compound, since multiple peaks must be correctly attributed Study design implications : Researchers studying interactions between compounds may specifically want a blend, whereas researchers isolating the effect of a single compound will generally want single-compound material like GHK-Cu Choosing Between a Single Compound and a Blend The right choice depends entirely on the research question: Studying the properties of a single, well-characterised compound single-compound peptides such as GHK-Cu are generally preferred for clarity of results Studying combined or comparative effects across multiple compounds a blend may be more appropriate, provided the exact composition is transparently documented Regulatory Note Neither GHK-Cu nor blended peptide products are licensed medicines or cosmetic ingredients approved for use on humans in the UK
Post-Viral & Cognitive Neuroscience 24 June 2026 Dihexa for EBV & Glandular Fever Brain Fog: Epstein-Barr Reactivation, the MS Link, Long COVID & the 2026 UK Review Can a synaptogenic peptide help Epstein-Barr virus (EBV) or glandular fever brain fog
First, we performed the OF test to exclude any influence of exploratory or locomotor activity on cognitive function evaluation
Click Here While we have been monitoring the situation around peptides and the FDA for several years, this particular decision came as a surprise to us
That tiny addition makes a world of difference
